Form 483

Apitoria Research Centre (A Division of Apitoria Pharma Private Limited) Form 483, 2024-05-24

FDA issued a Form 483 to Apitoria Research Centre (A Division of Apitoria Pharma Private Limited) on 2024-05-24 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Apitoria Research Centre (A Division of Apitoria Pharma Private Limited) · Sangareddy, India · Issued May 24, 2024

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

24 May 2024
21 CFR 211.68(b)

input/output verification

Cited by Teresa I Navas

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere